← Leaderboards
S. Ali Fatemi
Hugo W. Moser Res Inst Kennedy Krieger
$6,844,676
Attributed
$8,335,041
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,620,619 · 12
By mechanism
U54$14,540,127 · 4
P50$9,014,507 · 3
R61$2,631,051 · 2
R01$2,092,481 · 1
K08$896,708 · 1
R21$445,745 · 1
Top collaborators
- Florian S Eichler12 shared
- Adeline Lucie Vanderver12 shared
- Bradley L Schlaggar9 shared
- Laura Ann Adang2 shared
- Jaspreet Singh2 shared
- Richard Aplenc1 shared
- Robert W Grundmeier1 shared
Most similar at Hugo W. Moser Res Inst Kennedy Krieger
Same institution · by research overlap
- Michael Van Doren Johnston$16,567,736
- Kirby D Smith$0
- Kathleen Zackowski$498,577
- Paul A. Watkins$4,502,851
- James J. Pekar$6,409,160
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsResearch PersonnelTrainingCollaborationsCommunitiesBrainAffectResourcesMolecularAdvocacyUniversitiesFundingNatural HistoryMyelinInstitutionBaseAdultDevelopmental DisabilitiesFutureTranslational ResearchLeadershipChildIntellectual Functioning DisabilityBasic Science
Grant awards (44)
Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN)$1,753,747
U54 · FY2025 · NS
Intellectual and Developmental Disabilities Research Centers$1,184,001
P50 · FY2025 · HD
Database Harmonization for Creation and Validation of Outcome Assessments and Prediction Tools for Metachromatic Leukodystrophy (MLD)$1,049,035
R61 · FY2025 · NS
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy$752,390
R61 · FY2025 · NS · contact PI
Project 3: Clinically Meaningful Outcomes in LBSL$107,584
U54 · FY2025 · NS · contact PI
Intellectual and Developmental Disabilities Research Centers 2020$1,283,754
P50 · FY2024 · HD
Global Leukodystrophy Initiative Clinical Trials Network Gap Year Administrative Supplement$1,009,720
U54 · FY2024 · NS
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy$829,626
R61 · FY2024 · NS · contact PI
CLINICAL TRANSLATIONAL CORE$283,284
P50 · FY2024 · HD · contact PI
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)$1,377,421
U54 · FY2023 · NS
Intellectual and Developmental Disabilities Research Centers 2020$1,282,806
P50 · FY2023 · HD
ALD Healthy Planet Project$511,971
U54 · FY2023 · NS
CLINICAL TRANSLATIONAL CORE$283,284
P50 · FY2023 · HD · contact PI
Myelin Disorders Biorepository Project (MDBP) at the Biospecimen Exchange for Neurological Disorders (BioSEND)$143,448
U54 · FY2023 · NS
Validation of the GMFC-MLD$67,640
U54 · FY2023 · NS
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)$1,397,307
U54 · FY2022 · NS
Intellectual and Developmental Disabilities Research Centers 2020$1,281,942
P50 · FY2022 · HD
Analysis of DARS2 in Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL) Patient Neurons$445,745
R21 · FY2022 · NS · contact PI
CLINICAL TRANSLATIONAL CORE$283,284
P50 · FY2022 · HD · contact PI
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)$137,700
U54 · FY2022 · NS
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)$1,405,684
U54 · FY2021 · NS
Intellectual and Developmental Disabilities Research Centers 2020$1,282,758
P50 · FY2021 · HD
CLINICAL TRANSLATIONAL CORE$283,194
P50 · FY2021 · HD · contact PI
Utility of advanced MRI and wearable technology to identify sensory motor outcome measures in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL)$156,700
U54 · FY2021 · NS
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)$1,414,956
U54 · FY2020 · NS
Intellectual and Developmental Disabilities Research Centers 2020$1,282,916
P50 · FY2020 · HD
Targeted Therapies for Neonatal White Matter Injury$413,550
R01 · FY2020 · NS · contact PI
CLINICAL TRANSLATIONAL CORE$283,284
P50 · FY2020 · HD · contact PI
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)$1,582,885
U54 · FY2019 · NS
Intellectual and Developmental Disabilities Research Centers 2013$1,267,226
U54 · FY2019 · HD
Targeted Therapies for Neonatal White Matter Injury$416,216
R01 · FY2019 · NS · contact PI
Administrative Core$235,082
U54 · FY2019 · HD · contact PI
Development of Executive Function Measures for Clinical Trials in Down Syndrome$193,770
U54 · FY2019 · HD
Intellectual and Developmental Disabilities Research Centers 2013$1,267,226
U54 · FY2018 · HD
Targeted Therapies for Neonatal White Matter Injury$416,216
R01 · FY2018 · NS · contact PI
Administrative Core$255,030
U54 · FY2018 · HD · contact PI
Targeted Therapies for Neonatal White Matter Injury$416,216
R01 · FY2017 · NS · contact PI
Administrative Core$255,030
U54 · FY2017 · HD · contact PI
Targeted Therapies for Neonatal White Matter Injury$430,283
R01 · FY2016 · NS · contact PI
Study of White Matter Development in a Rodent Model of Perinatal Brain Injury$189,535
K08 · FY2013 · NS · contact PI
Study of White Matter Development in a Rodent Model of Perinatal Brain Injury$189,535
K08 · FY2012 · NS · contact PI
Study of White Matter Development in a Rodent Model of Perinatal Brain Injury$172,546
K08 · FY2011 · NS · contact PI
Study of White Matter Development in a Rodent Model of Perinatal Brain Injury$172,546
K08 · FY2010 · NS · contact PI
Study of White Matter Development in a Rodent Model of Perinatal Brain Injury$172,546
K08 · FY2009 · NS · contact PI